RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil

被引：0
|
作者：
Grell, Peter
Batko, Stanislav
Pirsthuk, Alina
Borilova, Simona
Polachova, Katerina
Mazuchova, Blanka
Tomasek, Jiri
Fabian, Pavel
Berkovcova, Jitka
Bardelcik, Miroslav
Obermannova, Radka
Buchler, Tomas
Kiss, Igor
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
613-135-2370-7650-2700; 3282-206-4957-326-5009-5024-5025; 3282-206-4957-326-5009-2386; 10; 2; 38092-25821; 38092-18412; 38092-18849; 8; 4;
D O I：
10.1200/JCO.2024.42.3_suppl.197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
  • [2] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
  • [3] QUAlity of LIfe and survival of meTAStatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS)
    Hamers, P.
    Vink, G.
    Elferink, M.
    Koopman, M.
    May, A. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S434 - S435
  • [4] Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
    Hamers, Patricia A. H.
    Vink, Geraldine R.
    Elferink, Marloes A. G.
    Stellato, Rebecca K.
    Dijksterhuis, Willemieke P. M.
    Punt, Cornelis J. A.
    Koopman, Miriam
    May, Anne M.
    CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 154 - 166
  • [5] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Koper, Agnieszka
    Wilenski, Slawomir
    Sledzinska, Paulina
    Bebyn, Marek
    Koper, Krzysztof
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10867 - 10877
  • [6] Survival analysis based on the grade of neutropenia in patients with metastatic colorectal cancer treated with trifluridine-tipiracil
    Avino Tarazona, V.
    Rodriguez Garces, M.
    Amor Urbano, M.
    Bolanos Naranjo, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S140 - S140
  • [7] Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
    Malik, Mateusz
    Michalak, Maciej
    Radecka, Barbara
    Gelej, Marek
    Jackowska, Aleksandra
    Filipczyk-Cisarz, Emilia
    Hetman, Katarzyna
    Foszczynska-Kloda, Malgorzata
    Kania-Zembaczynska, Beata
    Manka, Danuta
    Orlikowska, Marlena
    Rogowska-Dros, Hanna
    Bodnar, Lubomir
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [8] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Agnieszka Koper
    Sławomir Wileński
    Paulina Śledzińska
    Marek Bebyn
    Krzysztof Koper
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10867 - 10877
  • [9] Safety and efficacy of trifluridine/tipiracil plus bevacizumab in RAS mutated patients with metastatic colorectal cancer
    Michalaki, Vasiliki
    Theodosopoulos, Thedosios
    Vezakis, Antonios
    Papaconstantinou, Ioannis
    Kontis, Ioannis
    Dafnios, Nikolaos
    Frangoulidis, George
    Karandrea, Despina
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Celeste B. Burness
    Sean T. Duggan
    Drugs, 2016, 76 : 1393 - 1402
12345